Pfizer’s Centers for Therapeutic Innovation: An Open Innovation Case Study

By • on May 16, 2011

“Pfizer recently announced the formation of a network of academic collaborators to accelerate the translation of basic science into biologics-based drugs. According to Mikael Dolsten, M.D., Ph.D., president of Pfizer Worldwide Research & Development, the Centers represents a novel open innovation paradigm, combining the competencies of top academic research institutions with Pfizer’s leading drug development capabilities and research technologies.”

Click here to read the full case study, available on BioEndeavor.net.

Related Posts

Related Entries

Recent Entries

Leave a Comment

Purchase viagra online and purchase it from the good to cope with dependable and trustworthy pharmacy. Don't believe of the recommendation by a mantra but instead as suggestion that is useful since that might be really a correct move to make to think about. It's not just about general ease of doing all of your buying resting before your Computer, or around no prerequisite to depart your home or stand-in point, but additionally concerning the choices you might have barely considered overall. Visit the drugstore you might have handled earlier in the event that you know the thing you need precisely. Examine the options what, why and just how if, nevertheless, you will find neither particular needs or a drugstore to go to.